FDA has granted accelerated approval to Lumakras (sotorasib) a RAS GTPase family inhibitor, for adult patients with KRAS G12C ‑mutated locally advanced or metastatic non-small cell lung cancer, as determined by an FDA ‑approved test, who have received at least one prior systemic therapy.
The European Commission has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adults with unresectable malignant pleural mesothelioma.
The National Cancer Institute approved the following clinical research studies last month.
The aftermath of sexual misconduct at premier medical institutions rarely leaves visible traces: HR is brought in, confidentiality invoked, deals made. The case of Axel Grothey’s exit from Mayo Clinic is a notable exception.
In an expression of support for increasing funding for cancer research and prevention, the Bidens earlier this week endorsed the National Cancer Research Month.
Five researchers have received the 2021 New Discoveries Young Investigator Awards from the Bladder Cancer Advocacy Network.
Roswell Park Comprehensive Cancer Center has launched a dedicated neurofibromatosis care program.
The FY21 RCRP program announcements and General Application Instructions for the FY21 Department of Defense Rare Cancers Research Program to support research of exceptional scientific merit in the area of rare cancers research the following award mechanisms are posted on the Grants.gov website.
COVID-19 took a heavy toll on cancer care staff and providers, a report from the Association of Community Cancer Centers finds.
University of Virginia School of Medicine scientists have developed resources to advance genomics and cancer research.
